Boeing
BA
$216.14
-2.15%
Boeing is a global aerospace and defense leader, operating through three primary segments: Commercial Airplanes, Defense, Space & Security, and Global Services. It is one of only two major manufacturers of large commercial aircraft, competing directly with Airbus, and a top-tier defense contractor alongside Lockheed Martin and Northrop Grumman. The current investor narrative centers on Boeing's operational recovery from production and safety crises, with recent headlines highlighting accelerating deliveries, a major satellite contract from the USAF, and a stock rally driven by falling oil prices that could boost airline demand. However, the company still faces significant challenges, including a high debt load, negative free cash flow, and lingering margin pressures, making the stock a battleground between recovery optimists and skeptics.…
BA
Boeing
$216.14
Related headlines
Investment Opinion: Should I buy BA Today?
Based on the analysis, Boeing is rated a Buy. The thesis is that Boeing's operational recovery, evidenced by 13.96% YoY revenue growth and a major defense contract, will eventually translate into profitability and cash flow generation, driving the stock toward the analyst average target of $270.65, which implies 25.2% upside. The consensus recommendation is Buy, and the stock is trading at a PS ratio of 1.85x, below its historical average of 6-7x, suggesting undervaluation relative to its own history.
Sign up to view all
BA 12-Month Price Forecast
The AI assessment leans bullish, driven by strong revenue growth and a discounted valuation relative to history. However, confidence is medium due to the persistent negative free cash flow and high leverage. The key swing factor is whether Boeing can convert its top-line growth into bottom-line profitability. If the company achieves positive free cash flow in the next two quarters, the stance would be upgraded to high confidence. Conversely, if revenue growth decelerates or margins deteriorate further, the stance would be downgraded to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Boeing's 12-month outlook, with a consensus price target around $270.65 and implied upside of +25.2% versus the current price.
Average Target
$270.65
0 analysts
Implied Upside
+25.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$230 - $300
Analyst target range
The target price range is $230.00 (low) to $300.00 (high), with the high target implying a 38.8% upside and the low target implying a 6.4% upside. The wide spread of $70 suggests significant uncertainty about Boeing's recovery trajectory. The high target likely assumes a rapid recovery in commercial aircraft deliveries and margin expansion, while the low target may price in continued production issues and higher debt costs. The recent institutional ratings show a consistent 'Buy' bias, with no recent downgrades, indicating analysts are confident in the company's turnaround, but the wide range highlights the risks involved.
Bulls vs Bears: BA Investment Factors
Boeing presents a classic battleground between recovery optimism and financial fragility. The bull case is anchored by accelerating revenue growth, a strong defense contract, and a consensus Buy rating with 25% upside to the average target. However, the bear case is equally compelling, with negative free cash flow, a debt-to-equity ratio near 10x, and persistent underperformance versus the market. The most critical tension is whether Boeing can convert its revenue growth into sustainable profitability and positive cash flow. If it does, the stock is undervalued; if not, the high leverage and weak margins could lead to further downside. Currently, the evidence slightly favors the bulls given the analyst confidence and operational improvements, but the margin for error is thin.
Bullish
- Revenue Growth Accelerating: Q1 2026 revenue grew 13.96% YoY to $22.22B, with all segments contributing. This marks a strong recovery from the pandemic and production issues, signaling improving demand for commercial aircraft and defense products.
- Analyst Consensus is Buy: With 26 analysts, the average target price is $270.65, implying 25.2% upside from the current price of $216.14. The consensus recommendation is 'Buy' with a mean score of 1.68, reflecting strong confidence in the turnaround.
- Defense Contract Win: Boeing secured a major USAF satellite contract worth billions, reinforcing its defense segment's stability. This contract provides long-term revenue visibility and diversifies away from the cyclical commercial aerospace business.
- Falling Oil Prices Boost Demand: Recent oil price declines reduce airline operating costs, potentially accelerating fleet renewal orders. This macro tailwind supports Boeing's commercial airplane segment, which is critical for margin recovery.
Bearish
- Negative Free Cash Flow: Boeing's trailing twelve-month free cash flow is -$1.04B, indicating the company is still burning cash. This limits financial flexibility and raises concerns about its ability to service debt without further dilution or asset sales.
- High Debt-to-Equity Ratio: The debt-to-equity ratio stands at 9.98, extremely high, reflecting a massive debt load. Interest expenses of $616M in Q1 2026 consume a significant portion of operating income, pressuring profitability.
- Weak Profitability Metrics: Operating margin is -6.05% and net margin is 2.50%, with Q1 2026 net income of -$4M. The company is barely breaking even, and any operational hiccup could push it back into significant losses.
- Underperformance vs. Market: Boeing's 1-year return is -2.57% versus the S&P 500's +18.19%, a relative underperformance of -20.76%. This persistent weakness suggests investors are not yet convinced of a sustainable recovery.
BA Technical Analysis
Boeing's stock is in a broad downtrend over the past year, with a 1-year price change of -2.57%, while the S&P 500 gained 18.19% over the same period, resulting in a relative strength of -20.76%. The current price of $216.14 sits at 54.7% of its 52-week range (between $176.77 low and $254.35 high), indicating the stock is closer to the lower end of its range, which often suggests a value opportunity or a falling knife. The stock has underperformed the market across all timeframes, with 6-month change of -7.52% versus SPY's +7.96%, reflecting persistent selling pressure.
Beta
1.21
1.21x market volatility
Max Drawdown
-25.0%
Largest decline past year
52-Week Range
$177-$254
Price range past year
Annual Return
-2.6%
Cumulative gain past year
| Period | BA Return | S&P 500 |
|---|---|---|
| 1m | -1.1% | +0.3% |
| 3m | -4.9% | +4.0% |
| 6m | -7.5% | +8.3% |
| 1y | -2.6% | +20.2% |
| ytd | -5.1% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BA Fundamental Analysis
Boeing's revenue trajectory shows a mixed recovery: Q1 2026 revenue was $22.22 billion, up 13.96% year-over-year, but this follows a volatile pattern with Q4 2025 revenue of $23.95 billion and Q3 2025 revenue of $23.27 billion. The growth is driven by all segments, with Commercial Airplanes at $9.20 billion, Defense at $7.60 billion, and Global Services at $5.37 billion, but the commercial segment's recovery is still hampered by production constraints. The multi-quarter trend shows revenue stabilizing in the low-to-mid $20 billion range, but the YoY growth rate of 13.96% is a positive sign, though it may not be sustainable if supply chain issues persist.
Quarterly Revenue
$22.2B
2026-03
Revenue YoY Growth
+14.0%
YoY Comparison
Gross Margin
11.5%
Latest Quarter
Free Cash Flow
$-1.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BA Overvalued?
Given Boeing's negative net income in the most recent quarter (net income of -$4 million), the price-to-sales (PS) ratio is the most appropriate valuation metric, as earnings-based multiples are not meaningful. The trailing PS ratio is 1.85x, while the forward PE is 52.21x, implying the market expects a significant earnings recovery. The PS ratio of 1.85x is below the company's historical average of around 6-7x, suggesting the stock is trading at a discount to its own past, but this is justified by the company's weak profitability and high leverage.
PE
87.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
28.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Boeing's most pressing risk is its debt burden. With a debt-to-equity ratio of 9.98 and interest expenses of $616M in Q1 2026, the company is highly leveraged. This leverage amplifies the impact of any operational underperformance, as fixed interest costs must be paid regardless of revenue. Additionally, negative free cash flow of -$1.04B TTM means Boeing is not generating enough cash to cover its obligations, forcing it to rely on external financing or asset sales. The company's thin net margin of 2.50% provides little cushion against cost overruns or supply chain disruptions, which have plagued the commercial airplane segment in recent years.
FAQ
The key risks are: (1) Financial risk: high debt-to-equity of 9.98 and negative free cash flow of -$1.04B TTM, which could lead to dilution or liquidity issues; (2) Operational risk: production delays or quality issues could hurt margins and deliveries; (3) Macro risk: rising oil prices or a recession could reduce airline demand; (4) Competitive risk: Airbus's stronger production ramp could erode market share. The most severe risk is a liquidity crisis, which could cause the stock to fall to the 52-week low of $176.77, a -18.2% decline.
The 12-month forecast is moderately bullish. In the base case (50% probability), the stock is expected to reach $230-$270, with an average target of $270.65. In the bull case (30% probability), it could reach $270-$300, driven by strong execution and positive cash flow. In the bear case (20% probability), it could fall to $177-$230, if production issues or macro headwinds persist. The most likely scenario is the base case, assuming Boeing continues its gradual recovery without major disruptions.
Boeing is undervalued on a price-to-sales basis, with a PS ratio of 1.85x versus its historical average of 6-7x. However, on a forward earnings basis, the PE of 52.21x is high, reflecting expectations of a strong earnings recovery. The market is pricing in a significant turnaround, but the low PS ratio suggests the stock is not overvalued relative to its revenue generation. If the recovery materializes, the stock could re-rate higher; if not, the high forward PE could compress, leading to downside.
Boeing is a good buy for investors with a high risk tolerance and a long-term horizon. The stock offers 25.2% upside to the average analyst target of $270.65, and the PS ratio of 1.85x is below its historical average of 6-7x, suggesting undervaluation. However, the company has negative free cash flow and a high debt-to-equity ratio of 9.98, which adds risk. If you believe Boeing can execute its recovery and generate positive cash flow, the risk/reward is attractive. But if you prefer stable, profitable companies, Boeing may not be suitable.
Boeing is more suitable for long-term investment, given its cyclical nature and the time required for the recovery to play out. The stock has a beta of 1.205, making it more volatile than the market, which could lead to significant short-term swings. The company does not pay a meaningful dividend (yield of 0.2%), so investors rely on capital appreciation. A minimum holding period of 3-5 years is recommended to allow the company to de-leverage and return to profitability. Short-term traders might find opportunities in the volatility, but the risk is high.